Great Diamond Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
4,569
+245
| +6% | +$17.1K | 0.07% | 177 |
|
|
2025
Q1 | $318K | Sell |
4,324
-196
| -4% | -$14.4K | 0.09% | 137 |
|
|
2024
Q4 | $296K | Sell |
4,520
-351
| -7% | -$23K | 0.08% | 145 |
|
|
2024
Q3 | $380K | Sell |
4,871
-1,491
| -23% | -$116K | 0.1% | 130 |
|
|
2024
Q2 | $496K | Sell |
6,362
-460
| -7% | -$35.9K | 0.12% | 128 |
|
|
2024
Q1 | $462K | Sell |
6,822
-200
| -3% | -$13.6K | 0.11% | 137 |
|
|
2023
Q4 | $473K | Sell |
7,022
-660
| -9% | -$44.5K | 0.12% | 136 |
|
|
2023
Q3 | $520K | Sell |
7,682
-610
| -7% | -$41.3K | 0.14% | 126 |
|
|
2023
Q2 | $593K | Sell |
8,292
-106
| -1% | -$7.59K | 0.16% | 120 |
|
|
2023
Q1 | $583K | Buy |
8,398
+67
| +0.8% | +$4.65K | 0.17% | 117 |
|
|
2022
Q4 | $565K | Sell |
8,331
-22
| -0.3% | -$1.49K | 0.17% | 109 |
|
|
2022
Q3 | $458K | Buy |
8,353
+110
| +1% | +$6.03K | 0.16% | 126 |
|
|
2022
Q2 | $544K | Buy |
8,243
+1,883
| +30% | +$124K | 0.18% | 108 |
|
|
2022
Q1 | $421K | Buy |
6,360
+1,035
| +19% | +$68.5K | 0.12% | 139 |
|
|
2021
Q4 | $310K | Buy |
5,325
+485
| +10% | +$28.2K | 0.08% | 175 |
|
|
2021
Q3 | $290K | Buy |
4,840
+107
| +2% | +$6.41K | 0.08% | 169 |
|
|
2021
Q2 | $283K | Buy |
4,733
+283
| +6% | +$16.9K | 0.08% | 164 |
|
|
2021
Q1 | $221K | Buy |
4,450
+200
| +5% | +$9.93K | 0.07% | 185 |
|
|
2020
Q4 | $212K | Sell |
4,250
-1,533
| -27% | -$76.5K | 0.07% | 173 |
|
|
2020
Q3 | $316K | Sell |
5,783
-352
| -6% | -$19.2K | 0.12% | 118 |
|
|
2020
Q2 | $324K | Sell |
6,135
-154
| -2% | -$8.13K | 0.13% | 109 |
|
|
2020
Q1 | $280K | Buy |
6,289
+3,877
| +161% | +$173K | 0.14% | 97 |
|
|
2019
Q4 | $120K | Buy |
+2,412
| New | +$120K | 0.05% | 200 |
|